
Biodesix BDSX
$ 6.61
-1.64%
Quarterly report 2025-Q3
added 11-03-2025
Biodesix DSO Ratio 2011-2025 | BDSX
Annual DSO Ratio Biodesix
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 41.7 | 47.4 | 41.7 | 63.5 | 61.3 | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 63.5 | 41.7 | 51.1 |
Quarterly DSO Ratio Biodesix
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 42.2 | 34.4 | 41.3 | - | 45.7 | 51 | 54.1 | - | 33.5 | 34.7 | 50.2 | - | 18.3 | 15.7 | 51.8 | - | 56.3 | 90.8 | 53.2 | - | 152 | 329 | 184 | - | 61.2 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 329 | 15.7 | 73.7 |
DSO Ratio of other stocks in the Diagnostics research industry
| Issuer | DSO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
145 | - | -6.23 % | $ 30.6 M | ||
|
Akumin
AKU
|
57.4 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
291 | - | -61.36 % | $ 2.46 M | ||
|
Burning Rock Biotech Limited
BNR
|
31.7 | $ 21.0 | 1.82 % | $ 226 M | ||
|
Co-Diagnostics
CODX
|
101 | $ 0.18 | -1.55 % | $ 5.28 M | ||
|
Biocept
BIOC
|
112 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
66.3 | - | 0.22 % | $ 16.8 M | ||
|
Castle Biosciences
CSTL
|
49.2 | $ 39.22 | -0.24 % | $ 1.09 B | ||
|
Danaher Corporation
DHR
|
57 | $ 229.96 | -0.31 % | $ 168 B | ||
|
DarioHealth Corp.
DRIO
|
85.8 | $ 10.5 | -1.87 % | $ 298 M | ||
|
BioNano Genomics
BNGO
|
83.4 | $ 1.51 | 0.67 % | $ 1.92 M | ||
|
Exact Sciences Corporation
EXAS
|
29.9 | $ 101.9 | - | $ 18.9 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
90.8 | - | - | $ 562 M | ||
|
DexCom
DXCM
|
85 | $ 66.82 | -0.37 % | $ 25.8 B | ||
|
Enzo Biochem
ENZ
|
50.3 | - | -8.98 % | $ 14.8 K | ||
|
Fulgent Genetics
FLGT
|
77.4 | $ 26.28 | -0.79 % | $ 795 M | ||
|
Global Cord Blood Corporation
CO
|
112 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
67.2 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
11.7 K | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
122 | - | 0.12 % | $ 80.1 M | ||
|
DermTech
DMTK
|
80.6 | - | -11.32 % | $ 2.94 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
98.1 | - | - | $ 10.7 B | ||
|
CareDx, Inc
CDNA
|
76.4 | $ 18.79 | -1.49 % | $ 1.01 B | ||
|
Heska Corporation
HSKA
|
40.8 | - | - | $ 1.31 B | ||
|
Anixa Biosciences
ANIX
|
385 | $ 3.11 | -0.32 % | $ 99.2 K | ||
|
HTG Molecular Diagnostics
HTGM
|
101 | - | -20.0 % | $ 1.06 M | ||
|
IQVIA Holdings
IQV
|
78 | $ 226.18 | -0.65 % | $ 41 B | ||
|
Guardant Health
GH
|
49.2 | $ 102.07 | 1.46 % | $ 12.5 B | ||
|
Aspira Women's Health
AWH
|
50.7 | - | -6.19 % | $ 10.5 M | ||
|
Myriad Genetics
MYGN
|
51.3 | $ 6.17 | - | $ 559 M | ||
|
ENDRA Life Sciences
NDRA
|
7.11 | $ 4.55 | -4.41 % | $ 2.44 M | ||
|
Neogen Corporation
NEOG
|
66.6 | $ 7.05 | -0.07 % | $ 1.53 B | ||
|
Personalis
PSNL
|
55.8 | $ 7.93 | -0.5 % | $ 470 M | ||
|
Quidel Corporation
QDEL
|
116 | $ 29.0 | -1.02 % | $ 1.22 B | ||
|
National Research Corporation
NRC
|
33 | $ 18.42 | -1.26 % | $ 452 M | ||
|
RadNet
RDNT
|
34.9 | $ 71.33 | -0.22 % | $ 5.21 B | ||
|
Illumina
ILMN
|
61.3 | $ 131.5 | -0.94 % | $ 20.9 B | ||
|
Charles River Laboratories International
CRL
|
67.7 | $ 201.1 | -0.44 % | $ 10.3 B | ||
|
Soleno Therapeutics
SLNO
|
33.5 | $ 45.22 | -2.32 % | $ 1.82 B | ||
|
Quest Diagnostics Incorporated
DGX
|
46.5 | $ 174.8 | -0.4 % | $ 19.4 B | ||
|
Motus GI Holdings
MOTS
|
77.2 | - | -34.28 % | $ 263 K | ||
|
Laboratory Corporation of America Holdings
LH
|
54.1 | $ 252.06 | -0.4 % | $ 21.1 B | ||
|
ICON Public Limited Company
ICLR
|
68.5 | $ 182.26 | -0.4 % | $ 15 B | ||
|
IDEXX Laboratories
IDXX
|
43.6 | $ 681.09 | -0.18 % | $ 56.2 B | ||
|
Lantheus Holdings
LNTH
|
72 | $ 66.97 | -0.28 % | $ 4.63 B | ||
|
Mettler-Toledo International
MTD
|
63.7 | $ 1 404.2 | -0.72 % | $ 29.8 B |